Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03225677 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Novel Tracer Methods to Evaluate Muscle Protein Metabolism in Cirrhosis

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Sep 30, 2027 → Sep 30, 2028
See other at-risk trials from The Cleveland Clinic

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Sep 30, 2027 to Sep 30, 2028
    • Eligibility criteria expanded, about 10 words
  2. Primary and study completion dates: Sep 30, 2025 to Sep 30, 2027v10
  3. Re-verified, no change to tracked fieldsv9
  4. Primary and study completion dates: Sep 30, 2024 to Sep 30, 2025
    • Start date: Jul 3, 2017 to Aug 3, 2017
    v8
  5. Re-verified, no change to tracked fieldsv7
Show 5 earlier versionsHide 5 earlier versions
  1. Primary and study completion dates: Sep 30, 2022 to Sep 30, 2024v6
  2. Primary and study completion dates: Jul 30, 2021 to Sep 30, 2022v5
  3. Site contact updatedv4
  4. 2 versions Re-verified since Oct 5, 2018, no change to tracked fieldsv2-v3
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To determine the rate and mechanisms of skeletal muscle protein synthesis and breakdown in cirrhotic patients by using multiple tracers and single muscle biopsies.
Trial Details
NCT Number NCT03225677
Lead Sponsor The Cleveland Clinic
Conditions
(from sponsor)		 Cirrhosis
Related terms Fibrosis
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov